I don’t take note of HC metrics, nor do I think it translates into anything positive or negative for a particular security. All I know is based on my analysis, which has been extensive as mentioned above, fair value remains $0.175-$0.19. From current levels, there is approximately a 10-20% downside from current levels. Potentially more if there is a market wide crash following the Fed’s pivot.
Stonks92
CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-406
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.010(4.76%) |
Mkt cap ! $50.39M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 22.5¢ | 21.0¢ | $84.60K | 389.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 100224 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 23847 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| EYE (ASX) Chart |